In 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026.

Throughout this medical market research, we analyzed 43 cardiac surgery companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the US Cardiac Surgery Device market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Procedure Volumes for the Cardiac Surgery Devices
• Market Forecasts Until 2026, and Historical Data to 2016
• Competitive Analysis with Market Shares for Each Segment
• Market Drivers & Limiters for Each Cardiac Surgery Device Market
• Recent Mergers & Acquisitions
• COVID19 Impact on the Cardiac Surgery Device Market in the US
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

Cardiac Surgery Market Insights

A major limiter to the cardiac surgery market is the limited clinical data available for some of the newer markets. Growth in the cerebral embolic protection (CEPD) market may be limited until a large randomized clinical trial is conducted to determine the device’s exact role in reducing cerebral ischemic volumes. The CEPD market has experienced strong growth in recent years but may be unable to reach its full market potential without this additional clinical data.

A major driver in the cardiac surgery market is the patient population, which is large for many of the indications for cardiac surgery devices. Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves. This condition is typically present in patients who have several other co-morbidities, making them poor candidates for open, invasive surgery. Similarly, children with congenital defects would benefit from a percutaneous approach because they would not have to undergo repeated invasive procedures as they age.

COVID19 Impact on Cardiac Surgery Market in the US

The invasive cardiac surgery market is likely to be impacted the most severely by COVID-19. It is likely that the on-pump coronary artery bypass and off-pump coronary artery bypass market segments will decline as less invasive methods of treatment are preferred. This is expected to have a knock-on effect on other devices used in invasive surgery, such as anastomosis assist devices and endoscopic vessel harvesting devices.

The COVID19 impact on the transcatheter heart valve replacement (TAVR) market is likely to be similar to the balloon valvuloplasty, cerebral embolic protection, and preshaped guidewire markets. Conversely, the transcatheter mitral valve repair (TMVR) market will be severely impacted, as these procedures are resource-intensive and time-consuming. Overall, the US cardiac surgery market is expected to return to pre-COVID19 levels in early- / mid-2021.

Cardiac Surgery Market Share Insight

By 2020, Edwards Lifesciences was the competitive leader of the cardiac surgery and heart valve device market in the US. The company generated the majority of its total cardiac surgery and heart valve device revenue in the high-value transcatheter aortic valve replacement market. Edward’s Lifesciences pioneered the transcatheter aortic valve replacement segment, which is expected to experience significant growth propelled by the expanding indications for Edward’s devices to include low-risk patients.

Abbott was the second-leading competitor in the US cardiac surgery market by 2020. The company is the only competitor in the transcatheter mitral valve repair (TMVR) market, with its MitraClip™. The market is set to experience significant growth following approval of the device for secondary mitral regurgitation. Abbott is also the leading competitor in multiple structural heart defect occlusion devices.

The third-leading competitor in the cardiac surgery market in the US was Medtronic. The company’s strong position comes from its presence in the transcatheter heart valve replacement segment, with its CoreValve Evolut R® Transcatheter Aortic Valve Replacement product.

Detailed Market Segmentation

Each of the markets below is available for purchase as a standalone report, a MedCore.

• Procedure Volumes for Cardiac Surgery Market– MedPro – Using a number of databases, internal and external, we’re able to provide you with the volume of cardiac surgery procedures being performed in the US, including Surgical Heart Valve Replacement, Annuloplasty Repair, Transcatheter Mitral Valve Repair, Transcatheter Aortic Valve Replacement, Coronary Artery Bypass Grafting, Ventricular Assist Device, Heart Transplant, Intra-Aortic Balloon Counterpulsation, Atrial & Ventricular Septal Defect Closure, Left Atrial Appendage Closure procedures, and more.
• Tissue Heart Valve Market – MedCore – The market is further broken down into segments by:
  • Device Type: Stented, Stentless, Covered Stents, and Sutureless/Rapid Deployment;
  • Tissue Type: Xenograft and Allograft.
• Mechanical Heart Valve Market – MedCore – The market is also further segmented by Device Type into with and without conduit markets.
• Annuloplasty Repair Device Market – MedCore – The chapter contains the market analysis which is categorized by Ring and Band devices.
• Transcatheter Mitral Valve Repair Device Market – MedCore – In-depth analysis of the Transcatheter Mitral Valve Repair Device market.
• Transcatheter Heart Valve Replacement Market – MedCore – The market and its analysis are categorized into Transcatheter Aortic Value Replacement and Transcatheter Pulmonary Value Replacement markets.
• Cerebral Embolic Protection Device Market – MedCore – In-depth analysis of the Cerebral Embolic Protection Device market.
• Balloon Valvuloplasty Market – MedCore – The chapter is further broken down to Aortic, Mitral, Pulmonary, and Hybrid devices.
• On-Pump Coronary Artery Bypass Device Market – MedCore – The market is further broken down into ONCAB Disposables and Perfusion System market segments.
• Off-Pump Coronary Artery Bypass Device Market – MedCore – The analysis is further segmented by Stabilizer Device, Positioner, and OPCAB Accessories markets.
• Autotransfusion Device Market – MedCore – This market consists of the segments for the Autotransfusion Machine and Disposables.
• Endoscopic Vessel Harvesting Device Market – MedCore – The in-depth analysis of the Endoscopic Vessel Harvesting Device Market.
• Anastomosis Assist Device (AAD) Market – MedCore – The chapter takes a closer look at the different market segments, including Distal and Proximal anastomosis assist devices.
• Transmyocardial Revascularization Market – MedCore –The market analysis includes the segments, such as Single-Use Fibre-Optic Handpiece and TMR Laser Console markets.
• Ventricular Assist Device (VAD) Market – MedCore – The market analysis is further broken down by Device Type into Percutaneous, Implantable, and External VAD markets.
• Intra-Aortic Balloon Pump Market – MedCore – The analysis includes the Intra-Aortic Balloon Pump Catheter and Console markets.
• Artificial Heart Replacement Device Market – MedCore – In-depth analysis of the Artificial Heart Replacement Device market.
• Remote Hemodynamic Monitoring System Market – MedCore – In-depth analysis of the Remote Hemodynamic Monitoring System market.
• Patent Foramen Ovale Closure Device Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
• Patent Ductus Arteriosus Closure Device Market – MedCore – In-depth analysis of the Patent Ductus Arteriosus Closure Device market.
• Atrial Septal & Ventricular Septal Defect Closure Device Market – MedCore – The chapter contains the market analysis categorized by Atrial Septal Defect Closure and Ventricular Septal Defect Closure devices.
• Left Atrial Appendage Closure Device Market – MedCore – The market is further segmented by Device Type, such as Epicardial Device and Endocardial Device markets.
• Preshaped Guidewire Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
• Extracorporeal Membrane Oxygenation Market – MedCore – The detailed analysis of the Extracorporeal Membrane Oxygenation Market.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report